Zenotech Laboratories share news, announcements and annual reports
BSE: 532039Pharmaceuticals & BiotechnologySmall Cap
Zenotech Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1996
Last close ₹38.51up ₹0.56 (1.48%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹37.95.
30 Oct: open ₹38.44, high ₹38.80, low ₹38.00
52-week range of traded prices to 30 Oct 2026
₹33.55Low, 30 Mar 2026₹54.14High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹235 Cr2,190th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −8.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,968
Zenotech Laboratories board and management
25 filed, newest first.
Sep 2025
Mar 2025
Jul 2024
25 Jul · Management
May 2024
Jan 2021
Jul 2020
Feb 2020
Feb 2018
Nov 2017
Nov 2015
16 Nov · Management
Mr. Chinmoy Patnaik, Company Secretary and Compliance officer of the Company had resigned and relieved from his duties at the closing hours ....
Jul 2015
Jun 2015
2 Jun · Management
Zenotech Laboratories Ltd Dr. R. S. Bakshi, Independent Director of the Company, has resigned from the Board of the company effective from June 01, 2015.
May 2015
26 May · Management
Apr 2015
1 Apr · Management
Board of directors of the Company on April 01, 2015 appointed Smt. Kavita Shah and Mr. Vijay Agarwal as Additional Directors of the Company ....
Mar 2015
26 Mar · Management
Mr. K. L. Khurana, Independent Director and Chairman of the Company, has resigned from the Board with immediate effect.
Jun 2014
10 Jun · Management
Dr. Junichi Koga has resigned from his office as Director of the Company effective from June 06, 2014. In consequence thereof, Dr. ....
Feb 2014
24 Feb · Management
Mr. Bimal Kishore Raizada has resigned from the Board of Directors of the Company with immediate effect.
Jun 2013
19 Jun · Management
Mr. Chinmoy Patnaik, Company Secretary and Head of Legal of the Company has been appointed as the Compliance Officer of the Company effective ....
Dec 2012
6 Dec · Management
Oct 2012
4 Oct · Management
Dr. Jayaram Chigurupati has ceased to be the Managing Director of the Company upon completion of his term on September 30, 2012.
Dec 2011
14 Dec · Management
Board of Directors have vide resolution passed by circulation approved the appointment of Mr. Udbhav Ganjoo as an Additional (Non-executive ....
Aug 2011
18 Aug · Management
Board of Directors of the Company has appointed Dr. Sudershan K. Arora, Chairman as Executive Chairman of the Company with effect from ....
May 2011
19 May · Management
Company has appointed Mr. I Srinivas, an associate member of ICSI, New Delhi as the Company Secretary cum Compliance officer of the company ....
Feb 2010
26 Feb · Management
Board of Directors of the Company at its meeting held on February 26, 2010, have unanimously appointed the following Directors. 1. ....